{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:00:47Z","timestamp":1792839647732,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:p>Nonselective \u03b2\u2010blockers are useful to prevent bleeding in patients with cirrhosis and large varices but not to prevent the development of varices in those with compensated cirrhosis and portal hypertension (PHT). This suggests that the evolutionary stage of PHT may influence the response to \u03b2\u2010blockers. To characterize the hemodynamic profile of each stage of PHT in compensated cirrhosis and the response to \u03b2\u2010blockers according to stage, we performed a prospective, multicenter (tertiary care setting), cross\u2010sectional study. Hepatic venous pressure gradient (HVPG) and systemic hemodynamic were measured in 273 patients with compensated cirrhosis before and after intravenous propranolol (0.15 mg\/kg): 194 patients had an HVPG \u226510 mm Hg (clinically significant PHT [CSPH]), with either no varices (n = 80) or small varices (n = 114), and 79 had an HVPG &gt;5 and &lt;10 mm Hg (subclinical PHT). Patients with CSPH had higher liver stiffness (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), worse Model for End\u2010Stage Liver Disease score (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), more portosystemic collaterals (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01) and splenomegaly (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01) on ultrasound, and lower platelet count (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) than those with subclinical PHT. Patients with CSPH had lower systemic vascular resistance (1336 \u00b1 423 versus 1469 \u00b1 335 dyne \u00b7 s \u00b7 cm<jats:sup>\u20105<\/jats:sup>, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05) and higher cardiac index (3.3 \u00b1 0.9 versus 2.8 \u00b1 0.4 L\/min\/m<jats:sup>2<\/jats:sup>, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01). After propranolol, the HVPG decreased significantly in both groups, although the reduction was greater in those with CSPH (\u201016 \u00b1 12% versus \u20108 \u00b1 9%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01). The HVPG decreased \u226510% from baseline in 69% of patients with CSPH versus 35% with subclinical PHT (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and decreased \u226520% in 40% versus 13%, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001). <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>: Patients with subclinical PHT have less hyperdynamic circulation and significantly lower portal pressure reduction after acute \u03b2\u2010blockade than those with CSPH, suggesting that \u03b2\u2010blockers are more suitable to prevent decompensation of cirrhosis in patients with CSPH than in earlier stages. (H<jats:sc>epatology<\/jats:sc> 2016;63:197\u2013206)<\/jats:p>","DOI":"10.1002\/hep.28264","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T23:52:51Z","timestamp":1443657171000},"page":"197-206","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":184,"title":["Development of hyperdynamic circulation and response to \u03b2\u2010blockers in compensated cirrhosis with portal hypertension"],"prefix":"10.1097","volume":"63","author":[{"given":"C\u00e0ndid","family":"Villanueva","sequence":"first","affiliation":[{"name":"Hospital de la Santa Creu i Sant Pau,Universitat Aut\u00f2noma de Barcelona,Barcelona,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Albillos","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),Madrid,Spain"},{"name":"Hospital Universitario Ram\u00f3n y Cajal (IRYCIS),Universidad de Alcal\u00e1,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Genesc\u00e0","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),Madrid,Spain"},{"name":"Hospital Universitari Vall d'Hebron, Institut de Recerca (VHIR),Universitat Aut\u00f2noma de Barcelona,Barcelona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan G.","family":"Abraldes","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),Madrid,Spain"},{"name":"Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Institut Malalties Digestives i Metaboliques, IDIBAPS,Hospital Cl\u00ednic,Barcelona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Calleja","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Puerta de Hierro,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Aracil","sequence":"additional","affiliation":[{"name":"Hospital Arnau de Vilanova,Lleida,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Ba\u00f1ares","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),Madrid,Spain"},{"name":"Hospital General Universitario Gregorio Mara\u00f1\u00f3n (IISGM), Facultad de Medicina,Universidad Complutense,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Morillas","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),Madrid,Spain"},{"name":"Hospital Germans Trias,Badalona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Poca","sequence":"additional","affiliation":[{"name":"Hospital de la Santa Creu i Sant Pau,Universitat Aut\u00f2noma de Barcelona,Barcelona,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Pe\u00f1as","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),Madrid,Spain"},{"name":"Hospital Universitario Ram\u00f3n y Cajal (IRYCIS),Universidad de Alcal\u00e1,Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Augustin","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),Madrid,Spain"},{"name":"Hospital Universitari Vall d'Hebron, Institut de Recerca (VHIR),Universitat Aut\u00f2noma de Barcelona,Barcelona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Carles","family":"Garcia\u2010Pagan","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),Madrid,Spain"},{"name":"Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Institut Malalties Digestives i Metaboliques, IDIBAPS,Hospital Cl\u00ednic,Barcelona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana","family":"Pavel","sequence":"additional","affiliation":[{"name":"Hospital de la Santa Creu i Sant Pau,Universitat Aut\u00f2noma de Barcelona,Barcelona,Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Bosch","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd),Madrid,Spain"},{"name":"Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Institut Malalties Digestives i Metaboliques, IDIBAPS,Hospital Cl\u00ednic,Barcelona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2015,11,26]]},"reference":[{"key":"hep28264-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0950-3528(92)90031-9","article-title":"Natural history and prognosis of variceal bleeding","volume":"6","year":"1992","journal-title":"Baillieres Clin Gastroenterol"},{"key":"hep28264-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMra0901512","article-title":"Management of varices and variceal hemorrhage in cirrhosis","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"hep28264-bib-0003-20241017","first-page":"S121","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"hep28264-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2012.03.007","article-title":"Functional aspects on the pathophysiology of portal hypertension in cirrhosis","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"hep28264-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1053\/jhep.2001.27545","article-title":"Pharmacologic treatment of portal hypertension: past, present and future","volume":"34","year":"2001","journal-title":"Hepatology"},{"key":"hep28264-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","year":"2007","journal-title":"Gastroenterology"},{"key":"hep28264-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hep.23478","article-title":"Now there are many (stages) where before there was one: in search of pathophysiological classification of cirrhosis","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"hep28264-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","article-title":"Pharmacological treatment of portal hypertension: an evidence\u2010based approach","volume":"19","year":"1999","journal-title":"Semin Liver Dis"},{"key":"hep28264-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJM199105303242202","article-title":"Beta\u2010adrenergic\u2010antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices: an analysis of data and prognostic factors in 589 patients from four randomized clinical trials","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"hep28264-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta\u2010blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"hep28264-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"hep28264-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hep.1840150224","article-title":"Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal\u2010hypertensive rats","volume":"15","year":"1992","journal-title":"Hepatology"},{"key":"hep28264-bib-0013-20241017","first-page":"G205","article-title":"Interaction of flow and resistance in maintenance of portal hypertension in a rat model","volume":"250","year":"1986","journal-title":"Am J Physiol"},{"key":"hep28264-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"G980","DOI":"10.1152\/ajpgi.00336.2005","article-title":"Mild increases in portal pressure up\u2010regulate VEGF and eNOS in the intestinal microcirculation leading to hyperdynamic state","volume":"290","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"hep28264-bib-0015-20241017","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/gut.2010.235473","article-title":"Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis","volume":"60","year":"2011","journal-title":"Gut"},{"key":"hep28264-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jhep.2011.07.005","article-title":"Non invasive evaluation of portal hypertension using transient elastography","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"hep28264-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2012.11.015","article-title":"When the spleen gets tough, the varices get going","volume":"144","year":"2013","journal-title":"Gastroenterology"},{"key":"hep28264-bib-0018-20241017","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep.1840060119","article-title":"Short\u2010term effects of propranolol on portal pressure","volume":"6","year":"1986","journal-title":"Hepatology"},{"key":"hep28264-bib-0019-20241017","first-page":"180","article-title":"Propranolol\u2010a medical treatment for portal hypertension?","volume":"2","year":"1980","journal-title":"Lancet"},{"key":"hep28264-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","article-title":"Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review","volume":"131","year":"2006","journal-title":"Gastroenterology"},{"key":"hep28264-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/hep.25915","article-title":"New therapeutic paradigm for patients with cirrhosis","volume":"56","year":"2012","journal-title":"Hepatology"},{"key":"hep28264-bib-0022-20241017","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2010.03.021","article-title":"Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"hep28264-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/hep.20974","article-title":"Reversal of hepatic fibrosis\u2014fact or fantasy?","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"hep28264-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/hep.27249","article-title":"Prevention of portal hypertension: from variceal development to clinical decompensation","volume":"61","year":"2015","journal-title":"Hepatology"},{"key":"hep28264-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","article-title":"Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non\u2010response to propranolol","volume":"62","year":"2013","journal-title":"Gut"},{"key":"hep28264-bib-0026-20241017","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1053\/gast.1997.v112.pm9178694","article-title":"The portal pressure response to \u03b2\u2010blockers is greater in cirrhotic patients without varices than in those with varices","volume":"112","year":"1997","journal-title":"Gastroenterology"},{"key":"hep28264-bib-0027-20241017","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.1840050120","article-title":"Increased portal venous resistance hinders portal pressure reduction during the administration of \u03b2\u2010adrenergic blocking agents in a portal hypertensive model","volume":"5","year":"1985","journal-title":"Hepatology"},{"key":"hep28264-bib-0028-20241017","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0168-8278(01)00300-2","article-title":"Total effective vascular compliance in patients with cirrhosis. Effects of propranolol","volume":"36","year":"2002","journal-title":"J Hepatol"},{"key":"hep28264-bib-0029-20241017","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2005.10.024","article-title":"Effects of propranolol on venous compliance in conscious rats with pre\u2010hepatic portal hipertensi\u00f3n","volume":"44","year":"2006","journal-title":"J Hepatol"},{"key":"hep28264-bib-0030-20241017","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/hep.1840150511","article-title":"Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion","volume":"15","year":"1992","journal-title":"Hepatology"},{"key":"hep28264-bib-0031-20241017","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient: anything worth doing should be done right","volume":"39","year":"2004","journal-title":"Hepatology"},{"key":"hep28264-bib-0032-20241017","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jhep.2009.04.015","article-title":"Prognostic value of acute hemodynamic response to intravenous propranolol in patients with cirrhosis and portal hypertension","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"hep28264-bib-0033-20241017","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2009.03.048","article-title":"Acute hemodynamic response to beta\u2010blockers and prediction of long\u2010term outcome in primary prophylaxis of variceal bleeding","volume":"137","year":"2009","journal-title":"Gastroenterology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.28264","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.28264","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201601000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:17:13Z","timestamp":1729210633000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201601000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,26]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.28264","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,26]]},"assertion":[{"value":"2015-03-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-09-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}